
Fractional shares
Get dividend payments
Global stock markets soared in response to the news that American pharmaceuticals company Pfizer (PFE) has developed a vaccine, tested on 43,500 people, which it claims is 90% effective.
On the day of the announcement, Pfizer's share price rose 15%, before falling back and closing 7% up on the previous day. Other industries reacted positively to the news, with global economic hopes seemingly pinned on the vaccine.
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
Platform | Finder Score | Account fee | Min. initial deposit | Trade cost | Link |
---|---|---|---|---|---|
![]() |
9
Excellent
|
£0 | $100 | £1,795.98 |
Go to siteCapital at risk
|
![]() |
9.1
Excellent
|
£0 | £0 | £1,800.26 |
Go to siteCapital at risk
|
![]() |
9
Excellent
|
From £0 | £0 | £1,795.09 |
Go to siteCapital at risk
|
![]() |
8.8
Great
|
£0 | £0 | £1,783.15 |
Go to siteCapital at risk
|
![]() |
9.2
Excellent
|
£0 | £0 | £1,791.52 |
Go to siteCapital at risk
|
![]() |
8.5
Great
|
£0 (0.45% for funds) | £1 | £1,812.39 |
Go to siteCapital at risk
|
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Pfizer), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Pfizer is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
ETF |
Icon |
1-year performance (to May. '25) |
5-year performance (to May. '25) |
Link |
---|---|---|---|---|
Invesco S&P 500 ETF (SPXP) | ![]() |
5.90% | 97.34% | Invest Capital at risk |
Xtrackers S&P 500 Swap ETF 1C (XSPX) | ![]() |
5.86% | 96.92% | Invest Capital at risk |
iShares Core S&P 500 ETF USD (Acc) (CSP1) | ![]() |
5.83% | 95.53% | Invest Capital at risk |
HSBC S&P 500 ETF (HSPX) | ![]() |
4.64% | 84.36% | Invest Capital at risk |
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Pfizer's price performance, share price volatility, historical data and technicals.
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Historical closes compared with the last close of $24.2
1 week (2025-04-28) | 4.99% |
---|---|
1 month (2025-04-05) | 5.35% |
3 months (2025-02-05) | -6.46% |
6 months (2024-11-05) | -11.55% |
1 year (2024-05-05) | -12.98% |
2 years (2023-05-05) | -37.13% |
3 years (2022-05-05) | -50.65% |
5 years (2020-05-05) | -37.06% |
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Pfizer P/E ratio, PEG ratio and EBITDA.
Pfizer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Pfizer's shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Pfizer's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.
Pfizer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5659. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pfizer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Pfizer's PEG ratio in relation to those of similar companies.
Pfizer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $23.5 billion (£17.7 billion).
The EBITDA is a measure of Pfizer's overall financial performance and is widely used to measure a its profitability.
To put that into context you can compare it against similar companies.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Eli Lilly and Company? We explain how to invest in Eli Lilly in the UK along with platforms for buying stock.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Ever wondered how to buy shares in Walgreens? We explain how and compare a range of providers that can give you access to many brands, including Walgreens.
Ever wondered how to buy shares in Medtronic? We explain how and compare a range of providers that can give you access to many brands, including Medtronic.
Ever wondered how to buy shares in AstraZeneca? We explain how and compare a range of providers that can give you access to many brands, including AstraZeneca.
Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.